FRAJESE, Giovanni
 Distribuzione geografica
Continente #
EU - Europa 3.067
NA - Nord America 2.710
AS - Asia 1.777
SA - Sud America 59
AF - Africa 11
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 7
Totale 7.639
Nazione #
US - Stati Uniti d'America 2.689
IE - Irlanda 848
CN - Cina 732
SG - Singapore 525
DE - Germania 499
SE - Svezia 498
UA - Ucraina 386
IT - Italia 283
RU - Federazione Russa 280
TR - Turchia 195
HK - Hong Kong 154
FI - Finlandia 117
IN - India 103
GB - Regno Unito 60
BR - Brasile 47
VN - Vietnam 26
FR - Francia 23
NL - Olanda 18
JP - Giappone 15
AT - Austria 14
BE - Belgio 14
CA - Canada 14
ES - Italia 10
EU - Europa 8
AR - Argentina 7
IQ - Iraq 6
LT - Lituania 6
MX - Messico 5
ZA - Sudafrica 5
AU - Australia 4
PL - Polonia 4
IL - Israele 3
NZ - Nuova Zelanda 3
BD - Bangladesh 2
CO - Colombia 2
CZ - Repubblica Ceca 2
ID - Indonesia 2
IR - Iran 2
MY - Malesia 2
SA - Arabia Saudita 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BH - Bahrain 1
CI - Costa d'Avorio 1
CL - Cile 1
CU - Cuba 1
DK - Danimarca 1
DZ - Algeria 1
GI - Gibilterra 1
KE - Kenya 1
KZ - Kazakistan 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
NE - Niger 1
PA - Panama 1
PE - Perù 1
PK - Pakistan 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TN - Tunisia 1
TW - Taiwan 1
UZ - Uzbekistan 1
VE - Venezuela 1
Totale 7.639
Città #
Dublin 846
Chandler 584
Singapore 350
Jacksonville 292
Rome 212
Izmir 191
Nanjing 181
Hong Kong 154
Ashburn 150
Dallas 139
Boardman 127
The Dalles 126
Grafing 105
Beijing 94
Nanchang 78
Hefei 77
Lawrence 76
Princeton 76
Wilmington 73
Los Angeles 59
Moscow 59
Ogden 53
Brooklyn 47
Pune 45
Woodbridge 45
Ann Arbor 41
Inglewood 41
Munich 41
Des Moines 39
Seattle 36
Helsinki 34
Hebei 33
Dearborn 30
Shenyang 30
Milan 29
Tianjin 29
New York 26
Santa Clara 25
Kunming 23
Changsha 22
Council Bluffs 22
Orange 22
Brandenburg 20
Jiaxing 15
Verona 15
Mumbai 14
Tokyo 14
Ho Chi Minh City 13
Vienna 13
Brussels 12
Lanzhou 12
Changchun 10
Staten Island 10
Hangzhou 9
San Jose 9
Boston 8
San Francisco 8
Shanghai 8
Dronten 7
Jinan 7
Chennai 6
Chicago 6
Naaldwijk 6
Saint Petersburg 6
Stockholm 6
Turku 6
Montreal 5
Orem 5
Poplar 5
Atlanta 4
Bari 4
Denver 4
Hanoi 4
Johannesburg 4
London 4
Manchester 4
Mexico City 4
São Paulo 4
Walnut 4
Warsaw 4
Beaverton 3
Erbil 3
Formosa 3
Houston 3
Norwalk 3
San Mateo 3
Strasbourg 3
Toronto 3
Zhengzhou 3
Ankara 2
Auburn Hills 2
Auckland 2
Baena 2
Baghdad 2
Blumenau 2
Buffalo 2
Bình Dương 2
Cesena 2
Charlotte 2
Columbus 2
Totale 5.110
Nome #
Dynamic testing in the evaluation of male gonadal function. 136
Distribution of body fat in athletes users and non users of anabolic-androgens evaluated by dual-energy X-ray absorptiometry (DXA) 134
Different distribution of body fat in professional male soccer players and users of anabolic-androgens evaluated by dual-energy x-ray absorptiometry (DEXA) 131
Effect of transdermal androgen replacement therapy on cavernous vasodilation in eugonadal men with erectile dysfunction and low free testosterone: a pilot study 121
PAC1-R null isoform expression in human prostate cancer tissue. 121
Androgens and body composition in the aging male 118
Analysis of signal transduction stimulated by gonadotropins in granulosa cells. Mol.Cell.Endocrinol. Apr 28; 77-80 Con . 117
La prostata come organo endocrino recettivo e secretivo 116
Aldosterone promotes adipocyte differentiation in 3T3-L1 cells through specific activation of the mineralocorticoid receptor 116
A rare case of sigmoidal adenoma producing Cushing’s Syndrome 116
Changes in bone turnover markers and BMD in women with osteoporosis after PTH 1–84 treatment 116
Androgens and penile erection: evidence for a direct relationship between free testosterone and cavernous vasodilatation in men with erectile dysfunction 116
Body composition and bone mineral density in postmenopausal women: evidence for a major effect of mass 115
Evidence for a major effect of lean mass on bone mineral density in postmenopausal women 115
Hypothalamo-pituitary surveillance imaging in hypopituitary patients receiving long-term GH replacement therapy 113
PACAP and PACAP receptor expression in human normal, hyperplastic and neoplastic prostate tissue and tumor cell lines 112
Biologically active PAC1 receptor isoform in human neoplastic prostate 112
Pac1-r null isoform expression is upregulated in human prostate cancer tissue 111
PACAP and type I PACAP receptors in human prostate cancer tissue. 111
Hypothalamo-pituitary tumor surveillance imaging in patients taking GH replacement 110
Expression of the Growth Hormone Releasing Hormone Receptor (GHRH-R)/Vasoactive Intestinal Peptide Receptor (VIP-R)-like genes in the rat ovary 110
Insuline-Like Growth Factor I and the development of colorectal neoplasia in acromegaly 110
Leptin and testis: Ontogenesis of leptin receptor in rat Leydig cells 109
Body-fat distribution and responsiveness of the pituitary-adrenal axis to corticotropin-releasing-hormone stimulation in sedentary and exercising women 109
Post-natal stress-induced endocrine and metabolic alterations in mice at adulthood involve different pro-opiomelanocortin-derived peptides. 107
Gli antiandrogeni nella terapia degli iperandrogenismo adolescenziali 106
Dax-1 mutations and male infertility due to secretory azoospermia 105
Neurosteroids : a novel brain map for steroidogenesis 105
Penile pharmacotesting in diagnosing male erectile dysfunction: evidence for lack of accuracy and specificity. 105
Ontogenesis of leptin receptor in rat leydig cells. 105
Tadalafil in the treatment of erectile dysfunction; an overview of the clinical evidence 105
Re-dosing of prostaglandin-E1 versus prostaglandin-E1 plus phentolamine in male erectile dysfunction: a dynamic color power study 104
ACTH and alpha-MSH inhibit leptin expression and secretion in 3T3-L1 adipocytes: model for a central-peripheral melanocortin-leptin pathway. Feb 99-109. 104
The ectopic adrenocorticotropin syndrome: clinical features, diagnosis, management, and long-term follow-up. 102
Ocular metastases secondary to carcinoid tumours: the utility of radionuclide imaging with 123I-MIBG and 111 In-DTPA pentreotide 102
Strategies for new protocols of gene therapy in human prostate cancer cell lines using antiangiogenic factors 102
esercizio fisico ed ormoni 102
Valutazione della composizione corporea in atleti attraverso densitometria a raggi-x a doppia energia pulsata (DEXA) 101
Psychoneuroendocrine adaptation to the stress of performance: multiple aspects and one answer 101
miR-221 and miR-222 expression affects the proliferation potential of human prostate carcinoma cell lines by targeting p27Kip1 100
Regolazione paracrina della funzione ovocitaria 99
The Italian translation of the Handbook of Andrology (American Society of Andrology) 99
Studies on expression of antiangiogenic factors in human prostate cancer cell lines 99
Oral Pharmacological Therapies for erectile dysfunction: 3 years of clinical experience 99
Platelet-derived growth factor (PDGF) and PDGF receptors in rat corpus cavernosum: changes in expression after transient in vivo hypoxia 99
Anti-VEGF antisense inhibit neoangiogenic potential of prostate cancer cell lines 98
Functional Characterization of the Thr92Ala Variant of the Human Type 2 Deiodinase Gene 97
Leptin response to acute aerobic and anaerobic physical exercise in highly trained athletes 96
Neuroendocrinologia della riproduzione 96
Phosphodiesterase type 5 inhibithors in older males 95
Inquadramento diagnostico della disfunzione erettile 94
Human prostate cancer tissue expression of the PACAP receptor type 1 (PAC1) gene 94
PTH 1–84 and bone turnover markers in severe post-menopausal osteoporosis 94
Local radiotherapy increases the level of autoantibodies to ribosomal P0 protein but not to heat shock proteins, extracellular matrix molecules and EGFR/ErbB2 receptors in prostate cancer patients 94
Growth hormone-releasing hormone and pituitary adenylate cyclase-activating polypeptide in the reproductive system. con Dec. - 93
I disordini dello sviluppo puberale 93
Human placenta expresses only the SV2 isoforms of the PACAP receptor type 1 (PAC1) gene 92
La gonade fetale e la differenziazione sessuale 92
Sistema neuroendocrino intraprostatico e carcinogenesi ghiandolare ( 91
Leptin and androgens in male obesity: evidence for leptin contribution to reduced androgen levels. 91
Impaired Expression and Function of Cancer-Related Enzymes by Anthocyans: An Update 90
Neurosteroid biosynthetic pathways changes in prefrontal cortex in Alzheimer's disease 90
Plasma leptin levels after physical exercise in highly trained selected athletes 89
Modulation of cortisol metabolism during treatment of acromegaly is independent of body composition and insulin sensitivity 89
Sindromi da resistenza agli androgeni 88
The epidemiology of partialandrogen deficiency in aging men (PADAM). 88
PAC1-R null isoform expression is up-regulated in human prostate cancer tissue 88
Role of low TSH levels and high fracture risk in postmenopausal osteopenia and osteoporosis patients 85
The inhibition of the highly expressed miR-221 and miR-222 impairs the growth of prostate carcinoma xenografts in mice. 84
New achievement and novel therapeutic applications of PDE- 5 inhibithors in older males. 84
Ginecomastia 83
Sexual dimorphic evolution of metabolic programming in non-genetic non-alimentary mild metabolic syndrome model in mice depends on feed-back mechanisms integrity for pro-opiomelanocortin-derived endogenous substances. 83
Patologia della crescita 77
Immunity to extracellular matrix antigens is associated with ultrastructural alterations of the stroma and stratified epithelium basement membrane in the skin of Hashimotos thyroiditis patients 76
Identification of a novel mutation in the SRY gene in a 46, XY female patient 73
Neurosteroid biosynthetic pathway changes in substantia nigra and caudate nucleus in Parkinson's disease. 65
Totale 7.688
Categoria #
all - tutte 36.811
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.811


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021379 0 0 0 0 0 103 0 77 0 79 28 92
2021/2022485 2 0 3 22 22 1 120 35 17 4 125 134
2022/20232.434 166 185 104 179 132 513 0 117 955 4 42 37
2023/2024409 40 17 36 5 30 62 18 60 76 8 3 54
2024/20251.060 26 35 85 15 100 6 167 98 316 11 124 77
2025/20261.039 136 334 70 54 239 206 0 0 0 0 0 0
Totale 7.688